Elsevier Health Sciences Appoints Dr. David Gol...
PHILADELPHIA, Pennsylvania, May 4 /PRNewswire/ -- Elsevier, the leading
publisher of scientific, technical and
medical information, announced today that Dr. David Goldmann has joined
Elsevier Health Sciences as Vice President, Editor-in-Chief, First Consult.
As Editor-in-Chief, Dr. Goldmann is responsible for developing the overall
content strategy and vision and leading the entire content production of
First Consult and derivative products.
Michael Hansen, Chief Executive Officer, Elsevier Health
Sciences said of the appointment, "David's background and expertise will help
Elsevier become an even stronger knowledge partner, anticipating clinicians'
needs across disciplines and providing accurate, timely, evidence-based
answers to their questions.
First Consult is part of the Elsevier Health Sciences Clinical
Decision Support group that serves the information needs of healthcare
organizations and professionals across disciplines, including healthcare
researchers, practitioners, providers and payors. First Consult is an
authoritative evidence-based and regularly updated clinical information
resource for healthcare professionals. Designed for use at the point of care,
it provides instant, user-friendly access to the latest information on
evaluation, diagnosis, clinical management, prognosis and prevention.
Dr. Goldmann brings a wealth of experience in the medical
field. He is an internist and Associate Professor of Medicine at the
University of Pennsylvania and has held a number of editorial positions at
the American College of Physicians (ACP), where he was Editor-in-Chief of the
Physicians' Information and Education Resource (PIER), an evidence-based,
electronic medical knowledge resource; Associate, Deputy and Senior Deputy
Editor with the Journal Annals of Internal Medicine; and Consulting Editor to
ACP Internist and the ACP Foundation HEALTH TiPS patient education program.
Dr. Goldmann was educated at Harvard College, Harvard Medical
School and University of Sussex.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. Working in partnership with
the global science and health communities, Elsevier's 7,000 employees in over
70 offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult (
http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business
headquartered in Amsterdam, The Netherlands and has offices worldwide.
Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a
world-leading publisher and information provider. Operating in the science
and medical, legal, education and business-to-business sectors, Reed Elsevier
provides high-quality and flexible information solutions to users, with
increasing emphasis on the Internet as a means of delivery. Reed Elsevier's
ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK
and ENL (New York Stock Exchange).
Tom Reller
Director, Corporate Relations
+1-212-462-1912
T.Reller@Elsevier.com
Latest directors dealings
- 2 hours ago Oxford Nanopore Technologies
- 3 hours ago AVI Global Trust
- 3 hours ago LSL Property Services
- 3 hours ago Bluebird Merchant Ventures (DI)
- 3 hours ago Power Probe PLC